AstraZeneca Global Media site
AstraZeneca Australia is part of the global science-led biopharmaceutical company, AstraZeneca. We are engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. We are also selectively active in the areas of autoimmunity, neuroscience and infection. We build our own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia, we have been working to deliver the best value to patients for more than 60 years, and we push the boundaries of science to deliver life-changing medicines.
Our purpose and values help explain why we exist, what we hope to accomplish, the behaviours we value, how we will achieve our goals, and the promise of our brand to our stakeholders. We are a proud equal opportunity employer committed to cultivating an inclusive, safe and mutually respectful environment for every employee. We celebrate differences and will never discriminate based on nationality, race, ethnicity, age, diverse sexualities and genders, physical or mental disability, mental health condition, relationship status, religion, pregnancy, breastfeeding or family responsibilities, or other attributes protected by the law. We have global, regional and local Inclusion and Diversity committee to drive our strategy at all levels of our organisation and have six employee-led resource groups in ANZ which promote connection and allyship: LGBTQI, Women in Pharma, First Nations People, CarersConnect, Mental Health and Early Careers.
Driven by innovative science and our entrepreneurial culture, we are focused on the delivery of life-changing medicines that are fuelling growth and contributing value to patients and society.
Advancing high-potential late-stage pipeline projects, pursuing the next wave of disruptive biology and accelerating efforts in AI, data science and digital technology
Driving growth, impacting and improving the whole patient journey and collaborating with the funders of healthcare
Our commitment to society and our people